ClinicaliQ Trial Snapshot
- Improving Sedation Practice in Critically Ill Adult Patients Using a Co-designed Sedation Protocol — Recruiting • Cardiology / Cardiovascular • NCT07032987.
- What is being tested: A co-designed sedation protocol to optimise pain and sedation management in critically ill adult patients receiving extracorporeal membrane oxygenation (ECMO) support, aiming to standardise sedative and analgesic drug administration.
- Patient eligibility overview: Adult ICU patients requiring ECMO life support, who need sedation and analgesia to manage pain, reduce distress, and tolerate mechanical ventilation and the ECMO circuit.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Sedation (painkillers and sedative drugs) treats pain, reduces suffering, and helps patients in the intensive care unit (ICU) receiving extracorporeal membrane oxygenation (ECMO) remain comfortable. ECMO is a life support machine that provides oxygen and removes waste gases (carbon dioxide) in very sick patients with severe heart or lung failure. About 300-400 patients per year receive ECMO in the UK. These patients are younger and generally more healthy compared to other critically ill patients. However patients that survive ECMO have long-term health problems. These include anxiety, memory problems, withdrawal from…
Eligibility Snapshot
- Stage 1 (multi-centre observational study): Inclusion Criteria: 1. Aged 18 years and older. 2. Receiving continuous IV infusions of analgosedation (opioids, benzodiazepines, and/or propofol). 3. Receiving ECMO for moderate to severe respiratory failure (PaO2/FiO2 (P/F) ratio
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.